TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
15 hedge funds and large institutions have $1.1M invested in Titan Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
11% less capital invested
Capital invested by funds: $1.24M → $1.1M (-$138K)
Holders
15
Holding in Top 10
–
Calls
$720K
Puts
$211K
Top Buyers
| 1 | +$139K | |
| 2 | +$63K | |
| 3 | +$55.2K | |
| 4 |
VF
Virtu Financial
New York
|
+$50K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$32.7K |
Top Sellers
| 1 | -$162K | |
| 2 | -$6.67K | |
| 3 | -$5K | |
| 4 |
WPA
Winning Points Advisors
Boca Raton,
Florida
|
-$3.16K |